The largest database of trusted experimental protocols

Cre ert2

Manufactured by Jackson ImmunoResearch
Sourced in United States

Cre-ERT2 is a fusion protein consisting of the Cre recombinase enzyme and a mutated estrogen receptor ligand-binding domain (ERT2). It is designed for conditional gene expression in which Cre-mediated recombination is induced by the administration of tamoxifen or similar ligands.

Automatically generated - may contain errors

6 protocols using cre ert2

1

Conditional Knockout Mouse Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bcl11bF/F were previously described (Albu et al., 2007 (link); Albu et al., 2011 (link); Califano et al., 2014 (link); Li et al., 2010b (link); Zhang et al., 2010 (link)) and bred with cre-ERT2 mice and further with Rag1−/− mice. cre-ERT2, Rag1−/− and Rag2−/−γc−/− mice were from the Jackson Laboratories and Taconic Biosciences, respectively. All mice were housed in pathogenfree conditions. All experiments were conducted on 7–12 week old mice.
+ Open protocol
+ Expand
2

Murine Models for T Cell Immunology

Check if the same lab product or an alternative is used in the 5 most similar protocols
AST (Albumin-floxStop-SV40 large T antigen [Tag]) mice were provided by N.G. and G.J.H. from the German Cancer Research Center (Stahl et al., 2009 (link)). TCRSV40-I transgenic (B6.Cg-Tg(TcraY1,TcrbY1)416Tev/J) (Staveley-O’Carroll et al., 2003 (link)), Cre-ERT2 (B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/ J), Alb:Cre (B6.Cg-Tg(Alb-cre)21Mgn/J), C57BL/6J Thy1.2, and Thy1.1 (B6.PL-Thy1a/CyJ) mice were purchased from The Jackson Laboratory. TCRSV40-I mice were crossed to Thy.1.1 mice in our animal facility to generate TCRSV40-I Thy.1.1 mice. AST mice were crossed to Cre-ERT2 or Alb:Cre mice to obtain ASTxCre-ERT2 and ASTxAlb:Cre mice, respectively. OT-I TCR transgenic mice (Hogquist et al., 1994 (link)) were a gift from M. Bevan (University of Washington). Ly5.1 mice were purchased from The Jackson Laboratory. OT-I TCR transgenic mice were crossed to Ly5.1 mice to generate OT-I Ly5.1 mice. All mice were bred and maintained in a specific-pathogen-free barrier facility at the University of Washington and in the animal facility at Memorial Sloan Kettering Cancer Center. Experiments were performed in compliance with the University of Washington and Memorial Sloan Kettering Cancer Center Institutional Animal Care and Use Committee regulations.
+ Open protocol
+ Expand
3

Conditional Cyclin D1 Deletion Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse experiments were conducted in accordance with Institutional Animal Care and Committee (IACUC) protocols and Animal Resource Center (ARC) at Case Western Reserve University. Cre-ERT2 and Pten knockout mice were obtained from Jackson Laboratory. Sprr2f-Cre mice were provided by Dr. Leone. Cyclin D1Flox/WT mice were generated in Cyagen Biosciences Inc. Tamoxifen (Sigma) was administered orally to Cyclin D1Flox/WT Cre-ERT2 once a day for 5 days at a dose of 200mg/kg of body weight to generate Cyclin D1TA/WT mice. 1–2 mg of BrdU was administered by intraperitoneal injection two hours prior to analysis. The genotypes and DNA recombination were verified by genomic PCR. PCR primers are as follows: cyclin D1Flox/WT F1: 5’-GTGGAAGGCTTCCAGGTGTGAC-3’, R1: 5’-CCTAGTATGGACCCACAGACACCC-3’, F3: 5’-GCCCCATTCCTACATATCTCA-3’ and R3: 5’-TGGATCCACCTAATAACTTCGTA-3’.
+ Open protocol
+ Expand
4

Conditional Knockout Mice for Renal Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal studies and experimental procedures were performed according to the German animal care and ethics legislation and had been approved by the local government authority, the Committee on Research Animal Care, Regierungspräsidium Freiburg (G11/51 and X10/10H). The Moffl/fl (ref.13 (link)) and Nphs2-Cre mice57 (link) strains have been previously described. Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J and Cre-ERT2 mice were sourced from the Jackson Laboratory (JAX, Bar Harbor, ME, USA). All mice were maintained on a C57BL/6 background, kept under a 12-h light and dark cycle, and water and standard chow were available ad libitum. Drosophila melanogaster stocks were maintained on standard cornmeal molasses agar food at 25 °C. Experiments were performed at 29 °C for maximal efficiency of the GAL4/UAS-System. Sns-GCN-GAL4 (gift from Susan Abmayr) was used for targeted expression of UAS-Mof-RNA interference (VDRC TiD 105370).
+ Open protocol
+ Expand
5

Conditional Cyclin D1 Deletion Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse experiments were conducted in accordance with Institutional Animal Care and Committee (IACUC) protocols and Animal Resource Center (ARC) at Case Western Reserve University. Cre-ERT2 and Pten knockout mice were obtained from Jackson Laboratory. Sprr2f-Cre mice were provided by Dr. Leone. Cyclin D1Flox/WT mice were generated in Cyagen Biosciences Inc. Tamoxifen (Sigma) was administered orally to Cyclin D1Flox/WT Cre-ERT2 once a day for 5 days at a dose of 200mg/kg of body weight to generate Cyclin D1TA/WT mice. 1–2 mg of BrdU was administered by intraperitoneal injection two hours prior to analysis. The genotypes and DNA recombination were verified by genomic PCR. PCR primers are as follows: cyclin D1Flox/WT F1: 5’-GTGGAAGGCTTCCAGGTGTGAC-3’, R1: 5’-CCTAGTATGGACCCACAGACACCC-3’, F3: 5’-GCCCCATTCCTACATATCTCA-3’ and R3: 5’-TGGATCCACCTAATAACTTCGTA-3’.
+ Open protocol
+ Expand
6

Inducible Cardiac-Specific SIRT1 and PDH E1α Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 J wild type mice (4–6months), SIRT1flox/flox mice (stock number 008041), and CreERT2 (stock number 005657) mice were from Jackson Laboratory. Cardiomyocyte specific deletion of the SIRT1 gene mouse was generated by breeding SIRT1flox/flox mice with transgenic mice that carried an autosomally integrated Cre gene driven by the cardiac-specific alpha-myosin heavy chain promoter (αMHC) (CreERT2). The inducible cardiac-specific SIRT1 knockout (icSIRT1 KO) mice were generated by Tamoxifen injection (0.04 mg/g, i.p. 5 days) of CreERT2-SIRT1flox/flox (12 weeks old) mice, and SIRT1flox/flox mice (12 weeks old) with Tamoxifen injection were used for control groups. Cardiac-specific deletion of the PDHa1 gene was also generated by breeding PDH E1αflox/flox mice [37 ] with transgenic mice that carried an autosomally integrated Cre gene driven by the cardiac-specific aMHC (CreERT2). The inducible cardiac-specific PDH E1α knockout (icPDH E1α KO) mice were generated by Tamoxifen injection (0.04 mg/g, ip 5 days), and PDH E1αflox/flox (12 weeks old) mice with Tamoxifen injection were used for control groups. The genotying details were described in the Supplementary material online. All animal experiments were performed in compliance with NIH guidelines. And All animal protocols in this study were approved by the University of South Florida Institutional Animal Care and Use Committee.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!